1 / 2

Pressure Biosciences (OTC-PBIO) Stock Gains Momentum On Unusual Volume

Pressure Biosciences (OTCMKTS:PBIO) stock was in action last week as the stock went up from $0.75 on May 31st to reach a weekly high of $1 on Friday. Moreover, the stock had an unusual volume last week.<br><br>

thestreetreports
Download Presentation

Pressure Biosciences (OTC-PBIO) Stock Gains Momentum On Unusual Volume

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pressure Biosciences (OTC:PBIO) Stock Gains Momentum On Unusual Volume thestreetreports.com/pressure-biosciences-otcpbio-stock-gains-momentum-on-unusual-volume Pressure Biosciences (OTCMKTS:PBIO) stock was in action last week as the stock went up from $0.75 on May 31st to reach a weekly high of $1 on Friday. Moreover, the stock had an unusual volume last week. On June 1 New to the Street, which is produced by FME Media, announced that it had signed the company up on a 12-month contract for filming and broadcasting. The broadcasting is going to be focussed on commercials and interviews about Pressure Biosciences. The anchors from New to the Street are going to interview the management team at the company and each show would then be aired on the outlets on which the show is syndicated. It would be made available on Newmax, Fox Business Network, as a sponsored program on Bloomberg TV and it would also be available on the www.newtothestreet.com website. It was a major new development since it would provide pressure- based instrument manufacturing with a lot of publicity. On the same day, the company also made an announcement with regard to some of its aims and goals for the financial year of 2023. Here is a look at some of the highlights. The company seeks more than $1 million in annual 1/2

  2. nano-CBD commercial distribution contracts. Another objective is to sell two licenses related to its patented UltraShear platform for Nano THC. The company would also be looking to initiate production runs of its new strategic manufacturing facilities. DrDenese Skin Care, its business partner is also expected to complete the research and development phase of its first retinol product. 2/2

More Related